List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Comparison by Application (2021-2027)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Covered in This Study
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Key Manufacturers (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 19. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 23. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 27. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 31. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 35. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2016-2021)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2016-2021)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. MSD Corporation Information
Table 49. MSD Description and Business Overview
Table 50. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 52. MSD Recent Developments/Updates
Table 53. Sanofipasteur Corporation Information
Table 54. Sanofipasteur Description and Business Overview
Table 55. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 57. Sanofipasteur Recent Developments/Updates
Table 58. CDIBP Corporation Information
Table 59. CDIBP Description and Business Overview
Table 60. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 62. CDIBP Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 66. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 67. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
Table 69. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 70. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
Table 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2020 & 2027
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (?65)
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Dose)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2020
Figure 16. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2016-2021)
Figure 46. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 47. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 48. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 49. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 50. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 51. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 52. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE